Evaluation of CHROMagar candida for rapid identification and Etest for antifungal susceptibility testing in a district general hospital laboratory [1]

Journal of Clinical Pathology

Volumn 54, Issue 2, 2001, Pages 158-

  Ambler, J E ^a   Kerawala, M ^a   Yaneza, A ^a   Drabu, Y J ^a  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; GLUCOSE; ITRACONAZOLE;

CANDIDA ALBICANS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION; DRUG SENSITIVITY; FUNGUS IDENTIFICATION; HOSPITAL LABORATORY; IMMUNE DEFICIENCY; LABORATORY TEST; LETTER; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

CANDIDA; CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGICAL TYPING TECHNIQUES;

EID: 0035146521     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.2.158     Document Type: Letter

References (5)

1. Epidemiology of nosocomial fungal infections, with emphasis on candida species
2. Application of CHROMagar for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata
3. Fluconazole amphotericin B antifungal susceptibility testing by national committee for clinical laboratory standards broth macrodilution method compared with E-test and semi-automated broth dilution test
4. Antifungal susceptibility testing of yeasts: Evaluation of technical variables for test automation